| DrPOLÉKÉLÉKÉ vs Heihachi | 28–20 | 58.33% |
| DrPOLÉKÉLÉKÉ vs Kazuya | 12–19 | 38.71% |
| DrPOLÉKÉLÉKÉ vs Steve | 15–11 | 57.69% |
| DrPOLÉKÉLÉKÉ vs Jin | 12–13 | 48.00% |
| DrPOLÉKÉLÉKÉ vs King | 6–17 | 26.09% |
| DrPOLÉKÉLÉKÉ vs Law | 9–12 | 42.86% |
| DrPOLÉKÉLÉKÉ vs Hwoarang | 13–7 | 65.00% |
| DrPOLÉKÉLÉKÉ vs Yoshimitsu | 8–9 | 47.06% |
| DrPOLÉKÉLÉKÉ vs Lee | 9–5 | 64.29% |
| DrPOLÉKÉLÉKÉ vs Jun | 9–5 | 64.29% |
| DrPOLÉKÉLÉKÉ vs Asuka | 6–6 | 50.00% |
| DrPOLÉKÉLÉKÉ vs Azucena | 7–5 | 58.33% |
| DrPOLÉKÉLÉKÉ vs Eddy | 7–5 | 58.33% |
| DrPOLÉKÉLÉKÉ vs Xiaoyu | 2–8 | 20.00% |
| DrPOLÉKÉLÉKÉ vs Alisa | 2–8 | 20.00% |
| DrPOLÉKÉLÉKÉ vs Paul | 8–1 | 88.89% |
| DrPOLÉKÉLÉKÉ vs Bryan | 5–4 | 55.56% |
| DrPOLÉKÉLÉKÉ vs Dragunov | 3–6 | 33.33% |
| DrPOLÉKÉLÉKÉ vs Leroy | 6–3 | 66.67% |
| DrPOLÉKÉLÉKÉ vs Victor | 5–3 | 62.50% |
| DrPOLÉKÉLÉKÉ vs Devil Jin | 1–5 | 16.67% |
| DrPOLÉKÉLÉKÉ vs Shaheen | 2–3 | 40.00% |
| DrPOLÉKÉLÉKÉ vs Claudio | 1–3 | 25.00% |
| DrPOLÉKÉLÉKÉ vs Zafina | 3–1 | 75.00% |
| DrPOLÉKÉLÉKÉ vs Reina | 2–2 | 50.00% |
| DrPOLÉKÉLÉKÉ vs Lili | 2–1 | 66.67% |
| DrPOLÉKÉLÉKÉ vs Leo | 1–2 | 33.33% |
| DrPOLÉKÉLÉKÉ vs Lars | 2–1 | 66.67% |
| DrPOLÉKÉLÉKÉ vs Raven | 0–3 | 0.00% |
| DrPOLÉKÉLÉKÉ vs Lidia | 2–1 | 66.67% |
| DrPOLÉKÉLÉKÉ vs Jack-8 | 0–2 | 0.00% |
| DrPOLÉKÉLÉKÉ vs Nina | 0–2 | 0.00% |
| DrPOLÉKÉLÉKÉ vs Kuma | 1–1 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.